Prednisolone and Dactinomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prednisolone (prednisolone) and Dactinomycin (dactinomycin). Common drug interactions include febrile bone marrow aplasia among females and osteoporosis among males.

The phase IV clinical study analyzes what interactions people have when they take Prednisolone and Dactinomycin. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Prednisolone?

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 212,675 Prednisolone users. Check the latest studies of Prednisolone.

What is Dactinomycin?

Dactinomycin has active ingredients of dactinomycin. eHealthMe is studying from 2,577 Dactinomycin users. Check the latest studies of Dactinomycin.



On Jul, 14, 2026

35 people who take Prednisolone and Dactinomycin together, and have interactions are studied.

Prednisolone and Dactinomycin drug interactions.

What are the common drug interactions of Prednisolone and Dactinomycin, by gender? *:

female:

  1. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Mucosal inflammation (infection of mucous membrane)
  4. Weight decreased
  5. Vomiting
  6. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  7. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  8. Hepatic failure (liver failure)
  9. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  10. Hepatitis acute

male:

  1. Osteoporosis (bones weak and more likely to break)
  2. Constipation
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  5. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries))
  6. Lower respiratory tract infection
  7. Mucosal inflammation (infection of mucous membrane)
  8. Nausea (feeling of having an urge to vomit)
  9. Primary hypothyroidism (failure of the thyroid gland to produce or release thyroid hormones into the bloodstream)
  10. Pruritus (severe itching of the skin)

What are the common drug interactions of Prednisolone and Dactinomycin, by age (0-1 to 60+)? *:

0-1:

  1. Death
  2. Drug ineffective
  3. Haemorrhage intracranial (bleeding within the skull)
  4. Hospitalisation
  5. Neoplasm progression (growth of tumour)
  6. Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
  7. Pyrexia (fever)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Vomiting

2-9:

  1. Growth hormone deficiency
  2. Sinusitis (inflammation of sinus)

10-19:

  1. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Mucosal inflammation (infection of mucous membrane)
  4. Weight decreased
  5. Vomiting
  6. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  7. Disease recurrence
  8. Infection
  9. Bladder dysfunction
  10. Cytomegalovirus infection

20-29:

  1. Osteonecrosis (death of bone)

30-39:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Osteonecrosis (death of bone)

40-49:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  3. Hepatic failure (liver failure)
  4. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  5. Hepatitis acute
  6. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  7. Hypotension (abnormally low blood pressure)
  8. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  9. Thrombocytopenia (decrease of platelets in blood)

50-59:

  1. Pruritus (severe itching of the skin)
  2. Pyrexia (fever)
  3. Rash
  4. Rectal lesion
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  9. Lower respiratory tract infection
  10. Mucosal inflammation (infection of mucous membrane)

60+:

  1. Anaemia (lack of blood)
  2. Ewing's sarcoma (malignant small, round, blue cell tumour)
  3. Pneumonia

What are the existing conditions these people have? *

  1. Sarcoma Metastatic (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues spreads to other parts): 7 people, 20.00%
  2. Ewing's Sarcoma (malignant small, round, blue cell tumour): 4 people, 11.43%
  3. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 8.57%
  4. Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 2 people, 5.71%
  5. Haemangioma-Thrombocytopenia Syndrome (vascular tumour leads to decreased platelet counts and sometimes other bleeding problems): 2 people, 5.71%
  6. Gestational Trophoblastic Disease (disease of foetus surrounding during pregnancy): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisolone and Dactinomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prednisolone and Dactinomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dactinomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prednisolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dactinomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on prednisolone and dactinomycin (the active ingredients of Prednisolone and Dactinomycin, respectively), and Prednisolone and Dactinomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: